AIIMS Jodhpur Performs First Allogeneic Bone Marrow Transplant
In April 2026, AIIMS Jodhpur in Rajasthan successfully performed its first allogeneic bone marrow transplant, on a 23-year-old woman with acute myeloid leukaemia.
Transplant and donor
The patient’s younger brother donated the bone marrow and was found to be a full HLA match. The hospital reported encouraging improvement in her condition after the transplant.
Medical team and earlier procedure
Associate Professor Dr Pramod Kumar led the procedure, with Dr Arjun, Dr Anubhav Gupta and Dr Abhishek Purohit among the specialist team. AIIMS Jodhpur Executive Director Prof. G.D. Puri confirmed its successful completion. The hospital had previously performed its first autologous haematopoietic stem cell transplant in February 2025.
Important Facts for Exams
- HLA typing: High-resolution HLA typing compares multiple loci, commonly HLA-A, -B, -C and -DRB1; closer matching generally lowers, but cannot abolish, graft-versus-host disease risk.
- Graft-versus-leukaemia effect: Donor-derived immune cells can attack residual malignant cells in a graft-versus-leukaemia effect; this beneficial alloreactivity shares biology with graft-versus-host disease.
- Conditioning before infusion: Before donor-cell infusion, conditioning chemotherapy suppresses recipient immunity and creates marrow space; its intensity balances engraftment against treatment toxicity.
- AML transplant decisions: In acute myeloid leukaemia, allogeneic transplantation is often considered in first remission for intermediate- or adverse-risk disease, with genetic risk and measurable residual disease informing decisions.
Category: Rajasthan
Originally written on
April 25, 2026
and last modified on
November 19, 2026.
Tags: acute myeloid leukaemia, AIIMS Jodhpur, allogeneic bone marrow transplant, autologous haematopoietic stem cell transplant, HLA match, Rajasthan